Immunotherapy of murine leukemia VI. Development of immunologic memory in mice protected against friend leukemia virus-induced disease by passive serum therapy
- 1 January 1982
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 6 (4) , 577-593
- https://doi.org/10.1016/0145-2126(82)90014-5
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Oncogenicity of friend-virus-infected cells: Determination of origin of spleen colonies by the H-2 antigens as genetic markersInternational Journal of Cancer, 1978
- Immunotherapy of murine leukemia. I. protection against friend leukemia virus-induced disease by passive serum therapyInternational Journal of Cancer, 1978
- Antigenic modulation of Friend virus erythroleukemic cells in vitro by serum from mice with dormant erythroleukemia.The Journal of Experimental Medicine, 1977
- Prevention of oncornavirus-induced sarcomas in cats by treatment with antiviral antibodiesNature, 1977
- Studies on the role of the host immune response in recovery from Friend virus leukemia. I. Antiviral and antileukemia cell antibodies.The Journal of Experimental Medicine, 1976
- Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumorThe Journal of Experimental Medicine, 1975
- Passive immunisation of marmoset monkeys against neoplasia induced by a herpesvirusNature, 1975
- Rapid Cell Culture Assay Technique for Murine Leukaemia VirusesNature, 1971
- Prevention of carcinogenesis by murine sarcoma virus (Harvey) following injections of immune sera during the latent periodInternational Journal of Cancer, 1969
- DEFICIENCY OF THE FIFTH COMPONENT OF COMPLEMENT IN MICE WITH AN INHERITED COMPLEMENT DEFECTThe Journal of Experimental Medicine, 1967